Company profile: Gentronix
1.1 - Company Overview
Company description
- Provider of regulatory genotoxicity studies (GLP Ames, mouse lymphoma, in vitro micronucleus), predictive genotoxicity screening to detect liability early, skin toxicology assays for corrosion, irritation and sensitisation, and flow cytometry services. Includes Ames MPF/II and 24-well Agar formats requiring low test item amounts. Supports drug development and chemicals in cosmetics, personal care, and other chemistry driven industries.
Products and services
- Predictive Genotoxicity Screening: Offers low-input screens to detect genotoxic liability early in development, reducing test item usage and enabling safer product decisions across chemistry-driven industries
- Regulatory Genotoxicity Studies: Delivers GLP-compliant Ames, mouse lymphoma, and in vitro micronucleus studies to meet regulatory requirements and establish chemical safety for cosmetics and personal care applications
- Skin Toxicology: Supplies in vitro assays assessing dermal corrosion, irritation, and skin sensitisation, generating data to evaluate dermal toxicology potential for safer products in cosmetics and personal care.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Gentronix
Eurogentec
HQ: Belgium
Website
- Description: Provider of GMP biopharmaceutical manufacturing and life science solutions for research, diagnostic and pharmaceutical markets, including large-scale production of plasmid DNA, recombinant proteins, antibody fragments, mRNA, vaccines and conjugates; complex and NGS oligonucleotides; peptide-oligo conjugates; custom RNA/DNA aptamers; reagents and kits, in compliance with local and international standards.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurogentec company profile →
Core Diagnostics
HQ: United States
Website
- Description: Provider of full-service esoteric pathology laboratory services; a venture capital-backed laboratory based in Hayward, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Core Diagnostics company profile →
BioBridges
HQ: United States
Website
- Description: Provider of flexible expertise, services, and technologies for life sciences companies from discovery through commercialization, offering clinical operations, data management, regulatory affairs, safety & pharmacovigilance, biostatistics, and medical affairs to support studies, compliance, safety, and post-approval lifecycle.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioBridges company profile →
Eurofins
HQ: Luxembourg
Website
- Description: Provider of analytical testing and support services across pharmaceutical, food, environmental, and consumer products industries, including clinical diagnostics (sample collection, testing, counseling), environmental testing of water, air, soil and waste, cosmetics and personal care compliance testing, E&E product safety and approvals, maritime pollution and fuel/oil testing, and microbiological testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eurofins company profile →
ProPharma
HQ: United States
Website
- Description: Provider of independent, single-source regulatory, compliance, pharmacovigilance, and medical information services for pharmaceutical, biotechnology, and medical device companies; offering RCO custom solutions across the full product lifecycle, tailored MedTech solutions from concept to market, full-service Oncology CRO capabilities, global lifecycle solutions, and Prodigy technology to de-risk decision making and drive value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProPharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Gentronix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Gentronix
2.2 - Growth funds investing in similar companies to Gentronix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Gentronix
4.2 - Public trading comparable groups for Gentronix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →